Preferential Treatment: US FDA Asks Patients For Their Input

 
• By Ferdous Al-Faruque
  
Shuren_Jeff_1200
Michael McCaughan (left) speaking with CDRH Director Jeff Shuren at the Reagan-Udall Foundation for FDA on 2 May. • Source: Ferdous Al-Faruque
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation